Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill solid tumor cells. Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Pilot study to examine the effectiveness of interleukin-2 plus monoclonal antibody in treating patients who have solid tumors.
Key facts
- Study ID
- NCT00002994
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 355
- Starts
- 1997-07-01
- Expected to finish
- 2002-04-01
- Last updated by the study team
- 2016-06-28
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego Cancer Center — La Jolla, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- CCOP - Christiana Care Health Services — Wilmington, Delaware, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
- University of Illinois at Chicago Health Sciences Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
- Barnes-Jewish Hospital — St Louis, Missouri, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- CCOP - Southern Nevada Cancer Research Foundation — Las Vegas, Nevada, United States
- Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- CCOP - North Shore University Hospital — Manhasset, New York, United States
- North Shore University Hospital — Manhasset, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- New York Presbyterian Hospital - Cornell Campus — New York, New York, United States
- Mount Sinai Medical Center, NY — New York, New York, United States
- CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. — Syracuse, New York, United States
- State University of New York - Upstate Medical University — Syracuse, New York, United States
- Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.